爱朋医疗
(300753)
| 流通市值：14.83亿 | | | 总市值：22.68亿 |
| 流通股本：8240.89万 | | | 总股本：1.26亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 274,753,514.1 | 179,465,240.74 | 87,752,962 | 422,170,460.93 |
| 营业收入 | 274,753,514.1 | 179,465,240.74 | 87,752,962 | 422,170,460.93 |
| 二、营业总成本 | 271,029,178.03 | 176,068,376.14 | 86,636,436.82 | 415,602,661.18 |
| 营业成本 | 85,112,978.52 | 57,082,893.49 | 29,912,167.64 | 145,446,943.68 |
| 税金及附加 | 3,472,498.02 | 1,928,063.95 | 911,642.4 | 4,189,189.65 |
| 销售费用 | 100,705,131.68 | 59,739,038.78 | 24,765,360.77 | 147,710,315.48 |
| 管理费用 | 57,431,028.93 | 40,880,017.36 | 22,771,358.41 | 80,881,602.64 |
| 研发费用 | 23,409,768.84 | 15,740,917.42 | 7,677,023.64 | 36,549,133.77 |
| 财务费用 | 897,772.04 | 697,445.14 | 598,883.96 | 825,475.96 |
| 其中:利息费用 | 2,269,106.8 | 680,826.82 | 332,166.81 | 3,072,146.7 |
| 其中:利息收入 | 1,419,121.75 | 828,639.57 | 199,875.55 | 2,306,440.16 |
| 加:投资收益 | -598,285.1 | -535,151.2 | 85,115.95 | -1,438,422.34 |
| 资产处置收益 | 3,643,568.78 | 3,526,417.61 | - | 6,655.9 |
| 资产减值损失(新) | -113,597.17 | 192,421.79 | - | -470,734.61 |
| 信用减值损失(新) | -3,110,332.15 | 605,672.29 | 1,642,108.37 | -7,723,971.82 |
| 其他收益 | 9,428,807.57 | 8,180,424.86 | 1,263,464.93 | 17,025,165.06 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 12,974,498 | 15,366,649.95 | 4,107,214.43 | 13,966,491.94 |
| 加:营业外收入 | 941.14 | 565.37 | 838.32 | 180,826.61 |
| 减:营业外支出 | 2,476,736.18 | 2,078,681.4 | 2,002,597.43 | 338,537.13 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 10,498,702.96 | 13,288,533.92 | 2,105,455.32 | 13,808,781.42 |
| 减:所得税费用 | 6,626,807.72 | 4,490,921.39 | 978,147.17 | 5,358,727.18 |
| 六、净利润 | 3,871,895.24 | 8,797,612.53 | 1,127,308.15 | 8,450,054.24 |
| 持续经营净利润 | 3,871,895.24 | 8,797,612.53 | 1,127,308.15 | 8,450,054.24 |
| 归属于母公司股东的净利润 | 3,807,308.09 | 8,893,500.73 | 1,356,953.49 | 8,277,352.58 |
| 少数股东损益 | 64,587.15 | -95,888.2 | -229,645.34 | 172,701.66 |
| (一)基本每股收益 | 0.03 | 0.07 | 0.01 | 0.07 |
| (二)稀释每股收益 | 0.03 | 0.07 | 0.01 | 0.07 |
| 九、综合收益总额 | 3,871,895.24 | 8,797,612.53 | 1,127,308.15 | 8,450,054.24 |
| 归属于母公司股东的综合收益总额 | 3,807,308.09 | 8,893,500.73 | 1,356,953.49 | 8,277,352.58 |
| 归属于少数股东的综合收益总额 | 64,587.15 | -95,888.2 | -229,645.34 | 172,701.66 |
| 公告日期 | 2024-10-30 | 2024-08-17 | 2024-04-26 | 2024-04-26 |
| 审计意见(境内) | | | | 标准无保留意见 |